BACKGROUND: Hypnosedatives are commonly prescribed for anxiety and sleep problems. Changes in pharmacokinetics and pharmacodynamics of benzodiazepines (BZDs) during ageing may increase their potential to cause adverse outcomes. OBJECTIVE: This study aimed to investigate the use of BZDs in acute care settings and explore their association with falls. METHODS: A prospective cohort study was undertaken of patients aged over 70 years consecutively admitted to 11 acute care hospitals in Australia. Data were collected using the interRAI Acute Care assessment tool. Falls were recorded prospectively (in hospital) and retrospectively (in the 90 days prior to admission). RESULTS: Of 1,412 patients, 146 (10.3 %) were taking BZDs at admission and 155 (11.3 %) at discharge. Incidence rates of in-hospital fallers for users and non-users of BZDs were not statistically different [incidence rate ratio 1.03, 95 % confidence interval (CI) 0.58-1.82]. There was also no significant association between benzodiazepine use at admission and history of falls in the previous 90 days compared with non-users. However, patients on diazepam were significantly more likely to have a history of falls than all other benzodiazepine users (70.8 vs. 36.1 %; p = 0.002), particularly when compared with oxazepam users (70.8 vs. 25.0 %; p < 0.001). Adjusting for confounders, use of diazepam at admission was positively associated with a history of falls compared with all other benzodiazepine users (odds ratio 3.0; 95 % CI 1.1-8.5; p = 0.036). CONCLUSIONS: Different BZDs may vary in their propensity to predispose to falls, with diazepam having the strongest association. The selection of particular BZDs for older patients should be carefully evaluated.
BACKGROUND: Hypnosedatives are commonly prescribed for anxiety and sleep problems. Changes in pharmacokinetics and pharmacodynamics of benzodiazepines (BZDs) during ageing may increase their potential to cause adverse outcomes. OBJECTIVE: This study aimed to investigate the use of BZDs in acute care settings and explore their association with falls. METHODS: A prospective cohort study was undertaken of patients aged over 70 years consecutively admitted to 11 acute care hospitals in Australia. Data were collected using the interRAI Acute Care assessment tool. Falls were recorded prospectively (in hospital) and retrospectively (in the 90 days prior to admission). RESULTS: Of 1,412 patients, 146 (10.3 %) were taking BZDs at admission and 155 (11.3 %) at discharge. Incidence rates of in-hospital fallers for users and non-users of BZDs were not statistically different [incidence rate ratio 1.03, 95 % confidence interval (CI) 0.58-1.82]. There was also no significant association between benzodiazepine use at admission and history of falls in the previous 90 days compared with non-users. However, patients on diazepam were significantly more likely to have a history of falls than all other benzodiazepine users (70.8 vs. 36.1 %; p = 0.002), particularly when compared with oxazepam users (70.8 vs. 25.0 %; p < 0.001). Adjusting for confounders, use of diazepam at admission was positively associated with a history of falls compared with all other benzodiazepine users (odds ratio 3.0; 95 % CI 1.1-8.5; p = 0.036). CONCLUSIONS: Different BZDs may vary in their propensity to predispose to falls, with diazepam having the strongest association. The selection of particular BZDs for older patients should be carefully evaluated.
Authors: Allen R Huang; Louise Mallet; Christian M Rochefort; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn Journal: Drugs Aging Date: 2012-05-01 Impact factor: 3.923
Authors: John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra Journal: Arch Intern Med Date: 2009-11-23
Authors: Len C Gray; Roberto Bernabei; Katherine Berg; Harriet Finne-Soveri; Brant E Fries; John P Hirdes; Pálmi V Jónsson; John N Morris; Knight Steel; Sergio Ariño-Blasco Journal: J Am Geriatr Soc Date: 2008-01-04 Impact factor: 5.562
Authors: Sture Rognstad; Mette Brekke; Arne Fetveit; Olav Spigset; Torgeir Bruun Wyller; Jørund Straand Journal: Scand J Prim Health Care Date: 2009 Impact factor: 2.581
Authors: Leonard C Gray; Katherine Berg; Brant E Fries; Jean-Claude Henrard; John P Hirdes; Knight Steel; John N Morris Journal: BMC Health Serv Res Date: 2009-04-29 Impact factor: 2.655
Authors: Laurence Schumacher; Maria Dobrinas; Damien Tagan; Annelore Sautebin; Anne-Laure Blanc; Nicolas Widmer Journal: Drugs Real World Outcomes Date: 2017-12
Authors: Mohammad H Aljawadi; Abdullah T Khoja; Abdullah M Alhammad; Azzam D AlOtaibi; Sulaiman A Al-Shammari; Tawfik A Khoja Journal: Saudi Pharm J Date: 2018-05-31 Impact factor: 4.330
Authors: Andrea D Foebel; Hein P van Hout; Henriëtte G van der Roest; Eva Topinkova; Vjenka Garms-Homolova; Dinnus Frijters; Harriet Finne-Soveri; Pálmi V Jónsson; John P Hirdes; Roberto Bernabei; Graziano Onder Journal: BMC Geriatr Date: 2015-11-14 Impact factor: 3.921